- Home
- SBFM vs SPGC Comparison
SBFM vs SPGC Comparison
Compare SBFM & SPGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- SPGC
- Stock Information
- Founded
- SBFM 2006
- SPGC 2018
- Country
- SBFM United States
- SPGC United States
- Employees
- SBFM N/A
- SPGC N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- SPGC
- Sector
- SBFM Health Care
- SPGC
- Exchange
- SBFM Nasdaq
- SPGC Nasdaq
- Market Cap
- SBFM 3.7M
- SPGC 3.3M
- IPO Year
- SBFM N/A
- SPGC 2023
- Fundamental
- Price
- SBFM $2.90
- SPGC $0.29
- Analyst Decision
- SBFM Strong Buy
- SPGC
- Analyst Count
- SBFM 1
- SPGC 0
- Target Price
- SBFM $15.00
- SPGC N/A
- AVG Volume (30 Days)
- SBFM 151.9K
- SPGC 1.9M
- Earning Date
- SBFM 11-05-2024
- SPGC 03-17-2025
- Dividend Yield
- SBFM N/A
- SPGC N/A
- EPS Growth
- SBFM N/A
- SPGC N/A
- EPS
- SBFM N/A
- SPGC N/A
- Revenue
- SBFM $32,959,491.00
- SPGC $2,491,000.00
- Revenue This Year
- SBFM $59.94
- SPGC $899.43
- Revenue Next Year
- SBFM $164.69
- SPGC $49.83
- P/E Ratio
- SBFM N/A
- SPGC N/A
- Revenue Growth
- SBFM 61.94
- SPGC 840.00
- 52 Week Low
- SBFM $2.11
- SPGC $0.26
- 52 Week High
- SBFM $572.00
- SPGC $9.17
- Technical
- Relative Strength Index (RSI)
- SBFM 49.22
- SPGC 27.10
- Support Level
- SBFM $2.79
- SPGC $0.28
- Resistance Level
- SBFM $2.94
- SPGC $0.32
- Average True Range (ATR)
- SBFM 0.26
- SPGC 0.07
- MACD
- SBFM -0.03
- SPGC 0.04
- Stochastic Oscillator
- SBFM 16.70
- SPGC 3.07
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About SPGC Sacks Parente Golf Inc.
Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.